Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

2017202 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 18, Issue 3, pp. 404-412

Field-Weighted Citation Impact: 9.66